Perrigo (PRGO) Set to Announce Quarterly Earnings on Wednesday

Perrigo (NYSE:PRGO) is expected to release its Q3 2026 results before the market opens on Wednesday, November 4th. Analysts expect the company to post earnings of $0.5070 per share and revenue of $987.20 million for the quarter. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Individuals can find conference call details on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 8:30 AM ET.

Perrigo (NYSE:PRGO) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.11. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the prior year, the business earned ($0.06) earnings per share. The firm’s quarterly revenue was down 3.1% compared to the same quarter last year. On average, analysts expect Perrigo to post $2.17 EPS for the current fiscal year and $2.35 EPS for the next fiscal year.

Perrigo Trading Up 1.4%

PRGO stock opened at $16.04 on Wednesday. Perrigo has a twelve month low of $9.23 and a twelve month high of $21.84. The firm’s fifty day simple moving average is $14.69 and its two-hundred day simple moving average is $12.46.

Perrigo Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Friday, August 28th were issued a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 7.2%. The ex-dividend date was Friday, August 28th.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the stock. Weiss Ratings raised shares of Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a research note on Thursday, August 6th. Wall Street Zen lowered Perrigo from a “strong-buy” rating to a “buy” rating in a research report on Sunday, September 27th. One research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $17.50.

Perrigo Company Profile

Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter health products, wellness products and personal care items. Its portfolio includes products for allergy, pain relief, digestive health, skin care, smoking cessation, women’s health and other everyday health needs, along with vitamins, nutritional supplements and infant nutrition products.

Perrigo supplies products under its own brands, acquired brands and retailer-owned private-label labels.